Clinical Trial Update: Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness

View source ↗

Summary

A completed observational registry study assessing the comparative effectiveness of Cerebrolysin in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cerebrolysin

Snippet

Sponsor: Ever Neuro Pharma GmbH | Conditions: Acute Ischemic Stroke | Status: COMPLETED